期刊文献+

盐酸洛哌丁胺胶囊治疗婴幼儿腹泻病临床观察 被引量:4

The Clinical Observation of Infant Dysentery Treated by Loperamide Hydrochlo-ride Capsules
下载PDF
导出
摘要 目的:观察盐酸洛哌丁胺胶囊治疗婴幼儿腹泻病临床疗效。方法:选取泰和县妇幼保健院近年收治婴幼儿腹泻患儿98例,随机分为两组,对照组及观察组,各49例,对照组患儿给予蒙脱石散结合双歧杆菌四联活菌片进行治疗,观察组患儿给予蒙脱石散联合盐酸洛哌丁胺胶囊进行治疗,观察两组患儿治疗后临床总有效率及用药安全性。结果:观察组患儿治疗后临床症状好转时间与对照组比较无明显差异(P>0.05);观察组治疗总有效率(85.17%)略低于对照组(91.84%),差异无统计学意义(P>0.05);观察组各不良反应发生率与对照组相比,差异无统计学意义(P>0.05)。结论:盐酸洛哌丁胺胶囊应用于婴幼儿腹泻治疗中,临床疗效显著,使用安全性好,临床上可考虑使用。 Objective:To observe the clinical effect of infant dysentery treated by the Loperamide hydrochlo-ride capsules.Methods:98cases ofinfants with diarrhea at our hospital for treatment were randomly divided into two groups,the control group and the treatment group,with49casesin each.The control group was given the montmorillonite powder combines bifidobaeterium tetravaccine table for treatment,the treatment groupwas given the montmorillonite powder combines the loperamide hydrochlo-ride capsules for treatment,the clinical total efficacy rates after treatmentand drug safety of two groups were observed.Results:The improvement time of clinical symptoms after treatment in the treatment group showedno difference from the control group(P>0.05).The total treatment effective rate(85.17%)of the treatment group was slightly lower than the controlgroup(91.84%),but there was no statistical significance(P>0.05).Compared with the control group,the incidence of adverse reactions in theobservation group was not significant(P>0.05).Conclusion:The effect of loperamide hydrochlo-ride capsules for the treatment of infant dysenterywas obvious,and it has better security.
作者 罗仁烂 LUO Ren-lan(Department of Pediatrics, the Maternal and Child Care Service Centre of Taihe Country, Ji'an Jiangxi 343700, China)
出处 《药品评价》 CAS 2017年第11期62-64,共3页 Drug Evaluation
关键词 盐酸洛哌丁胺 婴幼儿腹泻 临床疗效 Loperamide Hydrochloride Infantile Diarrhea Clinical Effect
  • 相关文献

参考文献11

二级参考文献114

  • 1陈丽琼,包芸芸,高淑强.口服锌制剂联合思密达治疗小儿秋季腹泻疗效观察[J].儿科药学杂志,2006,12(2):26-27. 被引量:42
  • 2王井和,胡国华,胡爱华.α-2b干扰素联合肠炎宁治疗小儿秋季腹泻疗效观察[J].现代中西医结合杂志,2006,15(10):1307-1308. 被引量:1
  • 3方鹤松 魏承毓 段恕诚 等.腹泻病疗效判定标准的补充建议.中国实用儿科杂志,1998,13(6):384-384.
  • 4Yang B, erkman AS. Water and glycerol permeabilities of aquaporins 1-5 and MIP etermined quantitatively by expression of epitope-tagged constructs in Xenopus oocytes [ J ]. J Biol Chem, 1997, 272 (26) : 16140-16146.
  • 5Manley GT, Fujimura M, Ma T, et al. Aquaporin-4 deletion in mice re- duces brain edema after acute water in toxieation and ischemic stroke [ J ]. Nat Med, 2000, 6(2) : 159-163.
  • 6Bai C, Fukuda N, Song Y, et al. Lung fluid transport in aquaporin-1 and aquaporin-4 knockout mice [J]. J Clin Invest, 1999, 103(4) : 555-561.
  • 7Warth A, Eckle T, Khler D, et al. Upregulation of the water channel aquaporin-4 as a potential cause of postischemie cell swelling in a mu- rine model of myocardial infarction [ J]. Cardiology, 2007, 107 (4) : 402-410.
  • 8Wang KS, Ma T, Filiz F, et al. Colon water transport in transgenic mice lacking aquaporin-4 water channels [ J]. Am J Physiol Gastroint- est Liver Physiol, 2000, 279 (2) : G463-G470,.
  • 9Yamamoto T, Kuramoto H, Kadowaki M. Downragulation in aquaporin 4 and aqua-porin 8 expression of the colon associated with the induction of allergic diarrhea in a mouse model of food allergy [ J]. Life Sci, 2007, 81(2) : 115-120.
  • 10Yamamoto N, Sobne K, Miyachi T, et al. Differential regulation of aquaporin expression in astrocytes by protein kinase C [ J]. Brain Res Mol Brain Res, 2001, 95 ( 1-2 ) : 110-116.

共引文献244

同被引文献28

二级引证文献27

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部